Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WJB001 in Advanced Solid Tumors
NCT05773820Phase 2Active, not recruiting
- Sponsor
- Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Start
- May 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WJB001 in solid tumor (advanced stage), sponsored by Wigen Biomedicine Technology (Shanghai) Co., Ltd.. Started May 2023; status: active, not recruiting.
02
Drugs
WJB001
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05773820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05773820.